Please assess the completion status of the following clinical trial:

Trial Title: Phentolamine Mesylate as a Reversal of Local Anesthesics

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Previously diagnosticated to receive dental treatment according to Leonformacion's criteria~Exclusion Criteria:~* Hepatic or renal patient~* Fertility treatment, pregnancy or lactation~* Treatment with oral anticoagulants~* Patients with known allergies to anesthetics, excipients or phentolamine mesylate~* Patients with previous facial paresthesia~* Patients who had taken any painkiller or anti-inflammatory the day before~* Patients in which the anesthetic technique fails or has to be reinforced with more than two carpules

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- lidocaine (Type: EXPERIMENTAL): lidocaine 2% 1:80000
- articaine (Type: EXPERIMENTAL): articaine 4% 1:200000
- bupivacaine (Type: EXPERIMENTAL): bupivacaine 0,5% 1:200000

Based on this trial design, predict the completion outcome and termination type (if applicable).